Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological ResponsesChristian Pfister, Stéphane Culine, Aude Fléchon et al.|European Urology|2020Cited by 246
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years oldÉva Compérat, Christian Pfister, S. Larré et al.|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2015Cited by 227